共 50 条
- [2] Pregnancy outcomes in the ozanimod clinical development program in relapsing multiple sclerosis, Ulcerative Colitis, and Crohn's Disease JOURNAL OF CROHNS & COLITIS, 2021, 15 : S088 - S089
- [3] Pregnancy Outcomes in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis: Results From the Ozanimod Clinical Development Program AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S2 - S3
- [4] Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program JOURNAL OF CROHNS & COLITIS, 2022, 16 : I395 - I396
- [5] Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program JOURNAL OF CROHNS & COLITIS, 2022, 16 : I395 - I396
- [9] Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis JOURNAL OF CROHNS & COLITIS, 2022, 16 : I094 - I095